AI Briefing#life-sciences
The latest AI and developer news about #life-sciences, with the original source and a short summary.
The latest AI and developer news about #life-sciences, with the original source and a short summary.
Collaborations with partners like Generate Biomedicines and Divergence Labs yielded specific results, including a 70% shorter CAR T-cell design and 35,000 antibody designs generated in one month.
Principal investigators can apply for free access to Anthropic models and direct researcher support for projects in biology and drug discovery.
The acquisition combines Orchestra's coordination platform with OpenAI's Rosalind models to help biopharma teams manage the 10-15 year drug development process.
Eligible U.S. academic labs can receive up to 30 Business Standard seats for free for up to 12 months.
Anthropic has launched a beta verification program granting life sciences experts access to high-risk models.
LangChain has released 'Deep Life Sci', an open-source agent template for life sciences researchers.
OpenAI has released a research preview of 'Rosalind Workbench', an integrated workspace for life sciences researchers within the ChatGPT app.
In the ClinReg evaluation, Open-Weight LLMs showed accuracy comparable to closed-source models.
NVIDIA is integrating the BioNeMo Agent Toolkit into Anthropic's Claude Science to provide an AI-accelerated environment for life sciences research.
OpenAI has released LifeSciBench, an expert-validated benchmark designed to reflect real-world life sciences research processes.
Life sciences data platform Benchling is improving the accuracy of AI agents for scientific research through multi-model cross-validation and structured trace review.
OpenAI has unveiled the **GPT-Rosalind** update, combining GPT-5.5's agentic capabilities to strengthen life sciences research capacity.
Anthropic has significantly expanded Claude's capabilities to support research and clinical work in healthcare and life sciences.
Anthropic has improved Claude's performance for life sciences research and introduced scientific platform Connectors and Agent Skills.
Anthropic has partnered with the Allen Institute and HHMI to advance life science research and AI agent development using Claude.
Anthropic has launched the 'AI for Science' program, which provides researchers with API credits to accelerate scientific research.
Anthropic's Claude and Stanford's Biomni are transforming the entire scientific research process, dramatically increasing research speed.
OpenAI is launching Rosalind Biodefense and expanding access to GPT-Rosalind to respond to biological threats.
Anthropic is pursuing a $200 million, four-year AI collaboration with the Gates Foundation.
OpenAI unveiled GPT-Rosalind, a specialized AI tool for life sciences research, targeting early-stage drug discovery.
GPT-Rosalind has been released as a reasoning model to help with life sciences research and drug development.
Novartis CEO Vas Narasimhan has been appointed as a board member of Anthropic.
The OpenAI Foundation will invest at least $1 billion to address disease treatment and economic impact.
Anthropic is launching a new Science Blog covering the intersection of AI and science.